NYSE:CTVAChemicals
Corteva (CTVA) Valuation Check After Resurrect Bio Funding And Recent Share Price Momentum
Corteva (CTVA) is drawing fresh attention after leading Resurrect Bio’s US$8.1 million Series A round through its Corteva Catalyst platform. The move is aimed at supporting new crop protection traits and potential commercial partnerships.
See our latest analysis for Corteva.
Alongside the Resurrect Bio investment and a recently completed US$569.98 million share buyback, Corteva’s 30 day share price return of 8.49% and 90 day share price return of 16.81% suggest momentum has been building,...